• SENSEX 76,295.36
    -322.08 (--0.42%)
  • BANKNIFTY 51,597.35
    249.30 (+0.49%)
  • Mazagon Dock
    2,750.00 2,929.98(%)
  • Tejas Networks
    902.70 1,495.10(%)
  • Hind.Aeronautics
    4,328.95 5,675.00(%)
  • Kalyan Jewellers
    497.15 337.00(%)
  • Adani Power
    538.00 896.75(%)
  • TCS
    3,396.10 3,396.10(%)
  • Reliance Industr
    1,234.55 1,156.00(%)
  • Bharat Electron
    288.30 340.35(%)
  • Persistent Sys
    4,764.75 3,232.60(%)
  • Vodafone Idea
    8.06 6.60(%)
  • Tata Motors
    652.80 606.20(%)
  • Infosys
    1,485.10 1,359.10(%)
  • Angel One
    2,475.00 3,502.60(%)
  • Jio Financial
    231.75 394.70(%)
  • HDFC Bank
    1,776.70 1,430.15(%)
  • Nippon ETF Liq.
    1,000.01 1,005.00(%)
  • Reliance Power
    44.44 54.25(%)
  • Zomato Ltd
    208.35 146.85(%)
  • ICICI Pru. BSE
    999.99 998.75(%)
  • Emcure Pharma
    1,025.75 911.75(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bliss GVS Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 79.0
  • ISIN : INE416D01022
126.10 6 (5.00%)
  • As on 03 Apr 2025 (EOD)

  • Today’s Low

    120.76

  • Today’s High

    128.90

  • Open

    121.90

  • Perv Close

    120.10

  • 52W Low

    92.15

  • 52W High

    185.50

Key Indicators

  • P/E(TTM)

    16.39

  • Mar.Cap (₹Cr.)

    1,328.72

  • Div & Yield %

    0.39

  • Book Value(₹)

    97.23

  • Debt-Equity Ratio

    5.00

  • AGM Date

    03-Apr-2025

  • EPS

    7.70

  • P/E Ratio

    16.39

Financials Ratios

  • Debt-Equity Ratio

    0.11

  • Mar.Cap (₹Cr.)

    1,328.72

  • RONW (%)

    11.02

  • ROCE (%)

    14.84

Score Board

  • Equity (₹ in Cr.)

    10.54

  • BV (₹)

    97.20

  • Sales( ₹ in Cr.)

    605.46

  • NP (in Cr.)

    76.12

  • NP Var(%)

    -11.0

  • Div%

    50.0

  • CPS (₹)

    9.50

  • EPS (₹)

    7.20

  • Traded Value (₹ in Lakhs)

    1,329.77

  • 52 Week High

    185.50

  • 52 Week Low

    92.15

  • Price BSE

    126.0

  • Price NSE

    126.00

  • Market Capital( in Cr.)

    1,329.77

  • P/C Ratio

    13.30

  • P/E Ratio

    17.40

  • Price Vs.BV

    7.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 605.46 598.34 636.36 465.51 441.95 426.59
Excise Duty 600.18 594.44 624.07 458.25 434.11 414.49
Net Sales 605.46 598.34 636.36 465.51 441.95 426.59
Other Income 33.50 50.77 32.63 17.68 34.93 35.81
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 638.96 649.11 668.98 483.20 476.88 462.40
EXPENDITURE :
Raw Materials 600.18 594.44 624.07 458.25 434.11 414.49
Power & Fuel Cost 600.18 594.44 624.07 458.25 434.11 414.49
Employee Cost 82.59 72.54 65.06 58.61 44.02 33.85
Other Manufacturing Expenses 23.44 36.48 32.45 10.76 10.87 20.51
Selling & Administrative Expenses 66.73 66.90 67.07 36.90 40.01 43.93
Miscellaneous Expenses 23.44 36.48 32.45 10.76 10.87 20.51
Less : Pre-operative Expenses Capitalised :
Total Expenditure 527.62 533.41 545.33 392.01 355.17 342.39
Operating Profit 26.07 17.36 18.63 14.48 10.16 10.06
Interest 5.81 10.06 4.32 4.19 4.56 3.15
Gross Profit 70.26 115.69 126.40 91.19 121.71 120.01
Depreciation 23.52 15.17 13.85 13.76 8.83 5.75
Profit Before Tax 70.26 115.69 126.40 91.19 121.71 120.01
Tax 26.34 34.42 31.92 21.52 31.81 44.51
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -7.55 -4.21 0.77 1.17 -2.53 0.14
Reported Net Profit 50.64 85.48 92.66 67.50 92.33 74.43
Extraordinary Items 70.26 115.69 126.40 91.19 121.71 120.01
Adjusted Net Profit 50.64 85.48 92.66 67.50 92.33 74.43
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 5.23 5.21 5.18 5.16 5.16 10.31
P & L Balance carried down 50.64 85.48 92.66 67.50 92.33 74.43
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 50.00 50.00 50.00 50.00 50.00 100.00
Dividend Per Share(Rs) 0.50 0.50 0.50 0.50 0.50 1.00
Earnings Per Share-Unit Curr 4.85 8.23 8.97 6.54 8.95 7.22
Book Value 5.23 5.21 5.18 5.16 5.16 10.31
Book Value(Adj)-Unit Curr 5.23 5.21 5.18 5.16 5.16 10.31

Shareholding Pattern

  • Promoter Group

    35.10%

  • Public Share Holding

    64.90%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 36,987,174 35.10 36,987,174 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 36,987,174 35.10 36,987,174 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 14,232,847 13.51 14,232,847 42
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6,901,355 6.55 6,901,355 1
Mutual Funds / UTI 2,453 0.00 2,453 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 21,136,655 20.06 21,136,655 45
2] Non Institution
Bodies Corporate 7,325,052 6.95 7,280,612 201
Clearing Members 2,848 0.00 2,848 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,431,031 1.36 1,338,191 738
Foreign Non Institution Other 200 0.00 200 1
Hindu Undivided Families 1,155,271 1.10 1,155,271 830
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,803,680 9.30 9,803,680 5
Individuals holding nominal share capital up to Rs. 1 lakh 24,892,947 23.63 23,543,775 47,704
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2,528,670 2.40 2,528,670 3
Sub Total 47,242,443 44.84 45,755,991 49,506
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 105,366,272 100.00 103,879,820 49,558

Company Background

Bliss GVS Pharma LtdPharmaceuticals - Indian - Formulations

  • Bliss GVS Pharma Ltd
  • BSE Code : 79.0
  • ISIN : INE416D01022

  • Incorporation Year

    1984

  • Registered Office

    102 Hyde Park Sakivihar Road
    Andheri East, Mumbai,
    Maharashtra-400072

  • Telephone

    91-22-42160000

  • FAX

    91-22-28563930

  • Chairman

    Nandkumar Kashinath Chodankar

  • Managing Director

    Gagan Harsh Sharmma

  • Company Secretary

    Aditi Bhatt

  • Auditor

    Kalyaniwalla & Mistry LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Universal Capital Sec. Pvt Ltd
    21 Shakil Niwas,
    Mahakali Caves Road,Andheri (E)
    Mumbai - Mumbai - 400 093

Bliss GVS Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bliss GVS Pharma 126.20 638.96 605.46 28.88 11.19
Abbott India 29,940.35 6,097.18 5,848.91 47.68 44.71
Astrazeneca Phar 8,092.00 1,330.33 1,295.53 208.61 33.26
P & G Health Ltd 5,295.80 1,166.89 1,151.26 37.16 39.76
Glaxosmi. Pharma 2,857.90 3,530.73 3,407.25 56.83 44.44
Cipla 1,495.15 17,645.00 16,574.34 25.63 20.10
Novartis India 798.90 396.75 335.07 22.86 15.57
Amrutanjan Healt 666.30 437.58 421.23 39.06 20.84
Fermenta Biotec. 305.85 315.24 307.09 28.99 4.10
Guj. Themis Bio. 282.25 174.19 169.82 58.44 44.82
Ambalal Sarabhai 40.33 11.70 3.81 17.24 1.92